Found 75 results
Filters: Author is Nicholson, Jeremy K  [Clear All Filters]
Jiménez B, Mirnezami R, Kinross J, Cloarec O, Keun HC, Holmes E, Goldin RD, Ziprin P, Darzi A, Nicholson JK.  2013.  1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.. J Proteome Res. 12(2):959-68.
Stamler J, Brown IJ, Yap IKS, Chan Q, Wijeyesekera A, Garcia-Perez I, Chadeau-Hyam M, Ebbels TMD, De Iorio M, Posma J et al..  2013.  Dietary and urinary metabonomic factors possibly accounting for higher blood pressure of black compared with white Americans: results of International Collaborative Study on macro-/micronutrients and blood pressure.. Hypertension. 62(6):1074-80.
Want EJ, Masson P, Michopoulos F, Wilson ID, Theodoridis G, Plumb RS, Shockcor J, Loftus N, Holmes E, Nicholson JK.  2013.  Global metabolic profiling of animal and human tissues via UPLC-MS.. Nat Protoc. 8(1):17-32.
Lees HJ, Swann JR, Wilson ID, Nicholson JK, Holmes E.  2013.  Hippurate: The Natural History of a Mammalian-Microbial Cometabolite.. J Proteome Res.
Fonville JM, Carter CL, Pizarro L, Steven RT, Palmer AD, Griffiths RL, Lalor PF, Lindon JC, Nicholson JK, Holmes E et al..  2013.  Hyperspectral visualization of mass spectrometry imaging data.. Anal Chem. 85(3):1415-23.
Zheng X, Zhao A, Xie G, Chi Y, Zhao L, Li H, Wang C, Bao Y, Jia W, Luther M et al..  2013.  Melamine-induced renal toxicity is mediated by the gut microbiota.. Sci Transl Med. 5(172):172ra22.
Robinette SL, Lindon JC, Nicholson JK.  2013.  Statistical spectroscopic tools for biomarker discovery and systems medicine.. Anal Chem. 85(11):5297-303.
Pérez-Trujillo M, Lindon JC, Parella T, Keun HC, Nicholson JK, Athersuch TJ.  2012.  Chiral metabonomics: 1H NMR-based enantiospecific differentiation of metabolites in human urine via direct cosolvation with β-cyclodextrin.. Anal Chem. 84(6):2868-74.
Loo R L, Chan Q, Brown IJ, Robertson CE, Stamler J, Nicholson JK, Holmes E, Elliott P.  2012.  A comparison of self-reported analgesic use and detection of urinary ibuprofen and acetaminophen metabolites by means of metabonomics: the INTERMAP Study.. Am J Epidemiol. 175(4):348-58.
Holmes E, Li JV, Marchesi JR, Nicholson JK.  2012.  Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk.. Cell Metab. 16(5):559-64.
Kinross J, Nicholson JK.  2012.  Gut microbiota: Dietary and social modulation of gut microbiota in the elderly.. Nat Rev Gastroenterol Hepatol. 9(10):563-4.
Mestdagh R, Dumas M-E, Rezzi S, Kochhar S, Holmes E, Claus SP, Nicholson JK.  2012.  Gut microbiota modulate the metabolism of brown adipose tissue in mice.. J Proteome Res. 11(2):620-30.
Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S.  2012.  Host-gut microbiota metabolic interactions.. Science. 336(6086):1262-7.
Benton PH, Want E, Keun HC, Amberg A, Plumb RS, Goldfain-Blanc F, Walther B, Reily MD, Lindon JC, Holmes E et al..  2012.  Intra- and interlaboratory reproducibility of ultra performance liquid chromatography-time-of-flight mass spectrometry for urinary metabolic profiling.. Anal Chem. 84(5):2424-32.
Rainville PD, Smith NW, Cowan D, Nicholson JK, Shockcor J, Skilton S J, Plumb RS.  2012.  Investigation of basic mobile phases with positive ESI LC-MS for metabonomics studies.. Bioanalysis. 4(23):2833-42.
Nicholson JK, Everett JR, Lindon JC.  2012.  Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy.. Expert Opin Drug Metab Toxicol. 8(2):135-9.
Nicholson JK, Holmes E, Kinross JM, Darzi AW, Takats Z, Lindon JC.  2012.  Metabolic phenotyping in clinical and surgical environments.. Nature. 491(7424):384-92.